The Enterprise Value as of November 2024 (TTM) for Vaccinex, Inc. (VCNX) is 6.56M

According to Vaccinex, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 6.56M. This represents a change of 6.83% compared to the average of 6.14M of the last 4 quarters.

Vaccinex, Inc. (VCNX) Historical Enterprise Value (quarterly & annually)

How has VCNX Enterprise Value performed in the past?

The mean historical Enterprise Value of Vaccinex, Inc. over the last ten years is 35.36M. The current 6.56M Enterprise Value has changed 1.76% with respect to the historical average. Over the past ten years (40 quarters), VCNX's Enterprise Value was at its highest in in the June 2018 quarter at 91.39M. The Enterprise Value was at its lowest in in the June 2017 quarter at 0.

Vaccinex, Inc. (VCNX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Vaccinex, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Vaccinex, Inc. (VCNX) Average Enterprise Value

How has VCNX Enterprise Value performed in the past?

The current Enterprise Value of Vaccinex, Inc. (VCNX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Vaccinex, Inc. (VCNX) Enterprise Value vs. Peers

How is VCNX’s Enterprise Value compared to its peers?

Vaccinex, Inc.’s Enterprise Value is greater than Protara Therapeutics, Inc. (2.28M), less than Monopar Therapeutics Inc. (100.06M), less than Miromatrix Medical Inc. (90.06M), greater than Surrozen, Inc. (250.67K), less than First Wave BioPharma, Inc. (9.55M), greater than Salarius Pharmaceuticals, Inc. (-980791.00), less than SAB Biotherapeutics, Inc. (24.24M), less than GeoVax Labs, Inc. (19.24M), less than ZIVO Bioscience, Inc. (0), less than Theseus Pharmaceuticals, Inc. (73.95M), less than Erasca, Inc. (138.26M), less than Forte Biosciences, Inc. (747.42M), less than Applied Molecular Transport Inc. (7.03M), greater than RenovoRx, Inc. (-5743713.00), less than Anebulo Pharmaceuticals, Inc. (21.40M), less than Eledon Pharmaceuticals, Inc. (36.46M), less than null (233.30M),

Build a custom stock screener for Vaccinex, Inc. (VCNX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vaccinex, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vaccinex, Inc. (VCNX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vaccinex, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.